Proziso 25

Proziso 25

Generic Name:
Proziso 25
Therapeutic Category:
Antihistamine (First-Generation $H_1$-Receptor Antagonist) / Antiemetic / Sedative (Phenothiazine derivative)
Mechanism of Action:
Multi-receptor affinity. Promethazine competitively blocks peripheral and central $H_1$ histamine receptors, reducing allergic responses. It acts on the medullary chemoreceptor trigger zone (CTZ) by blocking dopaminergic ($D_2$) receptors to exert a strong antiemetic (anti-nausea) effect. Additionally, it exhibits significant anticholinergic (muscarinic) properties and central nervous system (CNS) depression, which provides its sedative and motion-sickness relief qualities.

Indications (Therapeutic Uses)

Promethazine 25 mg is a versatile therapeutic agent indicated for several conditions across allergic, gastrointestinal, and perioperative care:

  • Nausea and Vomiting: Prevention and control of severe nausea and vomiting associated with surgery, anesthesia, or systemic illness.
  • Motion Sickness: Prevention and active treatment of motion sickness (vestibular disturbances).
  • Allergic Conditions: Symptomatic management of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, and uncomplicated skin manifestations of urticaria (hives) and angioedema.
  • Sedation and Pre-operative Care: Used for pre-operative, post-operative, or obstetric sedation to relieve apprehension, induce light sleep, and reduce the requirement for concomitant opioid analgesics.

Dosage & Administration

Website Note: Dosage must be individualized by a registered medical practitioner based on the specific indication, patient age, and clinical response.

  • Standard Adult Dose (Allergy/Sedation): The typical dose is 25 mg taken orally before bedtime, or 12.5 mg to 25 mg taken before meals and at bedtime if required.
  • Standard Adult Dose (Anti-Nausea/Antiemetic): 25 mg taken orally as a single dose, which may be repeated every 4 to 6 hours as needed up to a maximum daily limit.
  • Standard Adult Dose (Motion Sickness): 25 mg taken twice daily. The first dose should be administered 30 to 60 minutes before travel, and the second dose 8 to 12 hours later if necessary.
  • Administration Method: Tablets should be swallowed whole with a glass of water. They can be taken with or without food. Taking the tablet with food or a glass of milk can help minimize mild gastrointestinal irritation.

Contraindications & Precautions

  • Pediatric Respiratory Warning (Black Box Warning): Do not use in pediatric patients less than 2 years of age. Promethazine carries a severe risk of fatal respiratory depression (profound slowing of breathing) in this population. Post-marketing cases of respiratory depression, including fatalities, have been reported. Use with extreme caution in children aged 2 years and older, employing the lowest effective dose.
  • Absolute Contraindications: Contraindicated in individuals with a known hypersensitivity to promethazine, other phenothiazines, or any inactive ingredients in the tablet formulation. Completely contraindicated in patients in a comatose state or those experiencing severe CNS depression from any source (such as alcohol, barbiturates, or narcotics).
  • Severe CNS Depression & Driving: Promethazine causes marked drowsiness and can impair the mental and physical abilities required for hazardous tasks. Patients must be strictly warned against driving, operating heavy machinery, or performing tasks requiring sharp alertness until their reaction to the medication is fully established.
  • Neuroleptic Malignant Syndrome (NMS): As a phenothiazine derivative, promethazine carries a rare but serious risk of inducing NMS. Monitor closely for signs such as hyperpyrexia (high fever), muscle rigidity, altered mental status, and irregular pulse or blood pressure. Discontinue treatment immediately if NMS is suspected.
  • Anticholinergic Effects: Due to its potent muscarinic receptor blockade, use with caution in patients with narrow-angle glaucoma, prostatic hypertrophy (enlarged prostate), bladder neck obstruction, or severe cardiovascular disease. It can cause urinary retention or dry out respiratory tract secretions.
  • Bone Marrow Suppression: Use with caution in patients with a history of bone marrow depression or those presenting with unexplained leukopenia (low white blood cell count).

Potential Side Effects

  • Common / Mild: Marked somnolence (excessive drowsiness), sedation, dry mouth, blurred vision, dizziness, confusion, disorientation, urinary retention, and mild gastrointestinal upset.
  • Less Common / Severe: Profound respiratory depression, Neuroleptic Malignant Syndrome, extrapyramidal symptoms (involuntary muscle movements, tremors, or restlessness), cholestatic jaundice (liver impairment), blood dyscrasias (such as agranulocytosis or leukopenia), and paradoxical central nervous system stimulation (especially in children, manifesting as excitability or nightmares).